Terasaki Institute for Biomedical Innovation Encourages People to Become Living Kidney Donors With PSA Airing on CBS

March 8, 2021

(Los Angeles) — Terasaki Institute for Biomedical Innovation has joined the OneLegacy Foundation and other like-minded organizations from around the country to help create an important public service announcement and website encouraging people to consider being a living kidney donor. The #BeLikeGina campaign launches this week in conjunction with National Kidney Month and is connected to CBS’s highly-acclaimed BPositive program.

Microneedle Patches For Microdosing Psychedelic Pharmaceuticals

February 22, 2021

(LOS ANGELES) – Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use. Research has shown that drugs such as MDMA (a type of methamphetamine), LSD and psilocybin (“magic mushrooms”) can be of benefit in treating severe pain, anxiety, depression and certain mental illnesses. Successful outcomes have been achieved when using psychedelics for treating conditions such as post-traumatic stress disorder and addictions to alcohol and smoking, for example. In many cases, these treatments have benefited individuals who had unsuccessfully tried to treat their conditions by other methods.

Breast Cancer-on-a-Chip For Testing Immunotherapy Drugs

February 1, 2021

(LOS ANGELES) – There are many mechanisms by which the body responds to foreign invaders.  One of these involves the T-cells of the immune system, which have a number of different proteins on their surface called “checkpoint proteins.”  These checkpoint proteins bind to proteins on the surface of other cells and can result in either stimulation or suppression of T-cell activity.  Normally, surface proteins on foreign or invading cells will produce a stimulation of T-cell activity against these cells, while T-cell suppression is a built-in mechanism to prevent the immune system from attacking the body’s own normal cells.  

2020 Year in Review: Championing Patient-Centered Work

January 19, 2021

With 2020 winding down, let’s take a moment to reflect on all that we have accomplished this year for the transplant and living donation community. Together with our partners, we launched the COVID-19 Kidney / Transplant Listening and Resource Center, designed new education for living donors and transplant recipients in partnership with the community, presented our work on digital storytelling and innovative education tools at talks and conferences hosted by the American Transplant Congress, Astellas Pharma Inc., One Lambda Inc., the 2020 Canadian Society of Transplantation Virtual Forum, and continued training new researchers and scientists in the field. We also published more than 20 new papers, book chapters, abstracts, and commentaries. This year we faced unprecedented challenges due to the COVID-19 pandemic, but we were able to pull together to meet those challenges in new and innovative ways to support highly at-risk patients. The transition to the remote environment has led us to some of our best projects yet!

Our Locations

Follow Us